Entera Bio Ltd
NASDAQ:ENTX 1:35:51 PM EDT
| Market Cap (Intraday) | 76.47M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.91 |
| 50-Day MA | $1.74 |
| 200-Day MA | $1.57 |
Entera Bio Ltd Stock, NASDAQ:ENTX
Kiryat Hadassah, Minrav Building, Jerusalem, Jerusalem 9112002
Israel
Phone: +972.2.532.7151
Number of Employees: 37
Description
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH, GLP-E, and hGh, The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.